165 related articles for article (PubMed ID: 29317377)
1. Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.
Valle LF; Greer MD; Shih JH; Barrett T; Law YM; Rosenkrantz AB; Shebel H; Muthigi A; Su D; Merino MJ; Wood BJ; Pinto PA; Krauze AV; Kaushal A; Choyke PL; Türkbey B; Citrin DE
Diagn Interv Radiol; 2018; 24(1):46-53. PubMed ID: 29317377
[TBL] [Abstract][Full Text] [Related]
2. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
[TBL] [Abstract][Full Text] [Related]
3. Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer.
Salerno KE; Turkbey B; Lindenberg L; Mena E; Schott EE; Brennan AK; Roy S; Shankavaram U; Patel K; Cooley-Zgela T; McKinney Y; Wood BJ; Pinto PA; Choyke P; Citrin DE
Brachytherapy; 2022; 21(4):442-450. PubMed ID: 35523680
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
[TBL] [Abstract][Full Text] [Related]
6. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.
Hegde JV; Demanes DJ; Veruttipong D; Raince J; Park SJ; Raman SS; Nickols NG; King CR; Kishan AU; Steinberg ML; Kamrava M
Brachytherapy; 2017; 16(6):1106-1112. PubMed ID: 28807747
[TBL] [Abstract][Full Text] [Related]
8. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.
Zattoni F; Kawashima A; Morlacco A; Davis BJ; Nehra AK; Mynderse LA; Froemming AT; Jeffrey Karnes R
Pract Radiat Oncol; 2017; 7(1):42-49. PubMed ID: 27527896
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multiparametric MRI-based and transrectal ultrasound-based preplans with intraoperative ultrasound-based planning for low dose rate interstitial prostate seed implantation.
Fredman ET; Traughber BJ; Gross A; Podder T; Colussi V; Vinkler R; Machtay M; Ellis RJ
J Appl Clin Med Phys; 2019 Jun; 20(6):31-38. PubMed ID: 31004396
[TBL] [Abstract][Full Text] [Related]
10. Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI.
Kitajima K; Hartman RP; Froemming AT; Hagen CE; Takahashi N; Kawashima A
AJR Am J Roentgenol; 2015 Oct; 205(4):807-16. PubMed ID: 26397329
[TBL] [Abstract][Full Text] [Related]
11. T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance.
Baur AD; Daqqaq T; Wagner M; Maxeiner A; Huppertz A; Renz D; Hamm B; Fischer T; Durmus T
Eur J Radiol; 2016 Jun; 85(6):1075-84. PubMed ID: 27161055
[TBL] [Abstract][Full Text] [Related]
12. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
Greer MD; Brown AM; Shih JH; Summers RM; Marko J; Law YM; Sankineni S; George AK; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2017 Feb; 45(2):579-585. PubMed ID: 27391860
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
14. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
18. Intra- and interreader reproducibility of PI-RADSv2: A multireader study.
Smith CP; Harmon SA; Barrett T; Bittencourt LK; Law YM; Shebel H; An JY; Czarniecki M; Mehralivand S; Coskun M; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
J Magn Reson Imaging; 2019 Jun; 49(6):1694-1703. PubMed ID: 30575184
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
20. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
